Leukemia, 0887-6924
Journal
Publications
- Article › Research › Not peer-reviewed
- Published
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia
& 2 others, , 1 Apr 2010, In: Leukemia. 24, 4, p. 877-881 5 p.Research output: Contribution to journal › Article
- Article › Research › Peer-reviewed
- Published
A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia
Charles Craddock, Jinlong Yin, Andy Howman, 7 Nov 2014, In: Leukemia. 29, p. 1478–1484 6 p.Research output: Contribution to journal › Article › peer-review
- Published
A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial
Sylvie Freeman, 31 Dec 2018, In: Leukemia. 5 p.Research output: Contribution to journal › Article › peer-review
- E-pub ahead of print
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia
Robert Hills, Sylvie Freeman, 30 Sep 2016, In: Leukemia.Research output: Contribution to journal › Article › peer-review
- Published
Acquired Isodisomy on Chromosome 13 at diagnosis results in impaired overall survival in Patients with FLT3-ITD mutant Acute Myeloid Leukaemia
Justin Loke, Kristian Brock, Paul Ferguson, Charles Craddock, Michael Griffiths & Manoj Raghavan, 2015, In: Leukemia. 29, 12, p. 2404-2407Research output: Contribution to journal › Article › peer-review
- Published
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
Charles Craddock, Sylvie Freeman, Manoj Raghavan, Robert Hills, Toon Brookes, Mark Griffiths & 5 others, , 2012, In: Leukemia. 27, 5, p. 1028-1036 9 p.Research output: Contribution to journal › Article › peer-review
- Published
- Published
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex
Giacomo Volpe, Jon Frampton, 24 Jan 2019, In: Leukemia. 33, p. 1608-1619 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
Jennifer Heaney, John Campbell, Alex Richter & Mark Drayson, Aug 2018, In: Leukemia. 32, 8, p. 1727–1738 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma
Katherine Eales, Wenbin Wei, Sarah Essex, Andrew Filer, Paul Moss, Dickens Pratt, Clare Davies & Daniel Tennant, Feb 2017, In: Leukemia. 31, 2, p. 373-381Research output: Contribution to journal › Article › peer-review
- Published
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
Anetta Ptasinska, Salam Assi, Maarten Hoogenkamp, Pierre Cauchy, Peter Cockerill & Conny Bonifer, 1 Aug 2012, In: Leukemia. 26, 8, p. 1829-1841Research output: Contribution to journal › Article › peer-review
- Published
Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia
Naeem Khan, Robert Hills & Sylvie Freeman, 31 May 2017, In: Leukemia. 31, 5, p. 1059-1068Research output: Contribution to journal › Article › peer-review
- Published
- Published
IMWG consensus on risk stratification in multiple myeloma
Keith Wheatley, Feb 2014, In: Leukemia. 28, 2, p. 269-77 9 p.Research output: Contribution to journal › Article › peer-review
- Published
Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3
Christopher Bunce & Geoff Brown, 1 Jan 1994, In: Leukemia. 8, 4, p. 595-604 10 p.Research output: Contribution to journal › Article › peer-review
- Published
Intensive chemotherapy with or without additional bone marrow transplantation in paediatric AML: Progress report on the MRC AML 10 trial
Keith Wheatley, Richard Gray & 9 others, , Jun 1992, In: Leukemia. 6, SUPPL. 2, p. 55-58 4 p.Research output: Contribution to journal › Article › peer-review
- Published
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
& 15 others, , Feb 2009, In: Leukemia. 23, 2, p. 215-24 10 p.Research output: Contribution to journal › Article › peer-review
- Published
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
Sudhesh Kumar & 19 others, , Oct 2009, In: Leukemia. 23, 10, p. 1716-30 15 p.Research output: Contribution to journal › Article › peer-review
- Published
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
Sudhesh Kumar & 21 others, , Oct 2009, In: Leukemia. 23, 10, p. 1904-12 9 p.Research output: Contribution to journal › Article › peer-review
- Published
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
Sudhesh Kumar & Keith Wheatley, Sep 2009, In: Leukemia. 23, 9, p. 1545-56 12 p.Research output: Contribution to journal › Article › peer-review